Shinpoong Pharmaceutical to Acquire Hyundai Pharm Shares Worth 29.6 Billion Won, Raising Stake to 7.2%

Shinpoong Pharmaceutical announced on the 26th that it will acquire 2,307,929 shares of Hyundai Pharm, a pharmaceutical manufacturing and sales company, for about 29.6 billion won.

After the share acquisition, Shinpoong Pharmaceutical's stake in Hyundai Pharm will be 7.2%. The scheduled acquisition date is the 27th.

Shinpoong Pharmaceutical stated that the purpose of this share acquisition is "to create business synergies through a strategic alliance and to strengthen the research and development (R&D) partnership."

Shinpoong Pharmaceutical Ansan Piramax dedicated factory. Shinpoong Pharmaceutical